By

riverbiomedics
New Investor Libertatis Ergo Holding joins the financing round alongside existing investors FIRST Fund, KIKK Capital and Oost NLfunding to further progress its pipeline of cardiovascular disease targets, taking its total seed financing to €3.8 millionOver €2 million in non-dilutive grant funding from EIC (European Innovation Council) to enable the further advancement of its technology...
Read More
We are pleased to announce that we have been granted €1.45 million from the EIC-Transition to bring our hiPSC-3D cardiac strips into a high throughput setting. In this project, we will miniaturize,  automate and scale-up the production of human 3D cardiac strips by combining 3D cardiac tissues derived from human induced pluripotent stem cell (hiPSC)...
Read More
We are happy to announce that we have received a €4 Million grant from the EIC-Pathfinder Challenge. This grant will fund the development of a pumping human Mini-heart and swimming human Bio-Robot by a consortium composed of two companies, River BioMedics (RBM) and NanoScale Systems (Nanoss) GmbH and two universities, the University of Twente and Universidad de Málaga . The project will be...
Read More
River BioMedics presented during the poster session of the European Organ-on-Chip Society (EUROoCS) 2021 conference as part of the collaboration with the Applied Stem Cell Technologies (AST) group, lead by Prof. Robert Passier from the University of Twente.
Read More
River BioMedics was featured as one of the inventions emerging from the University of Twente. Read more in the interview with our Scientific Advisory Board member Prof. Albert van den Berg, in the local newspaper Tubantia!
Read More
In an interview with the local newspaper Tubantia, we explain how we are building our 3D cardiac models and why our high-throughput technology is crucial to perform large drug screens for pharmaceutical companies.
Read More
Tom is joining River BioMedics as an assistent scientist, specialised in microfluidics and organ-on-chip. He will be working on the development of River BioMedic’s high-throughput platform. Happy to have him on board!
Read More
River BioMedics was featured in “Nederland maakt het” a Dutch television show about innovative companies in The Netherlands. Watch our item below to hear more about what we do to improve cardiac drug discovery!
Read More
Together with researchers from the Leiden University Medical center and the University of Twente, and in collaboration with NCardia we are going to develop a heart-on-chip model to determine the effects of a COVID19 infection and of COVID19 pharmacotherapies on the heart. For this project we received funding from Health~Holland.
Read More
1 2